Journal
JOURNAL OF IMMUNOLOGY
Volume 171, Issue 5, Pages 2187-2191Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.171.5.2187
Keywords
-
Categories
Ask authors/readers for more resources
The number and localization of effector cells to the tumor site are crucial elements for. immune rejection of solid tumors. However, for cerebral malignancies, antitumor responses need to be finely tuned to avoid neuropathologic consequences. In this study, we determine factors that regulate CTL localization and tumoricidal function after intracerebral implantation of tumors expressing model Ag. H-2(bxd) mice implanted with a CW3(+) murine glioma lkacking H-2K(d) molecules necessary to present the CW3(170-179) epitope demonstrate cross-priming of H-2K(d)-restricted CTL, and moreover, Ag-dependent accumulation of functional H-2K(d)/CW3(170-179)-specfic CTL within the tumor bed. This implicates a role for cross-Presentation not only in priming, but also in retention of fully differentiated CTL in the tumor stroma at the effector stage of the response. Modulating cross-presentation of Ag may be the key in regulating specific immune responses in the brain: either by augmenting protective responses or by down-modulating destructive autoimmune reactions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available